Colorectal cancer: highlight the clinical research current progress
Colonoscopy is the gold‑standard screening method for colorectal cancer (CRC) and reduces long‑term incidence and mortality.
Colorectal cancer (CRC) is a highly prevalent malignancy and a leading cause of cancer‑related mortality globally, necessitating the exploration of innovative diagnostic and therapeutic strategies. This review systematically examines recent advancements in CRC research, particularly focusing on early diagnostic methodologies, novel surgical techniques, radiotherapy and chemotherapy, as well as immunotherapy and targeted therapies. The review emphasizes the importance of early diagnosis and innovative surgical strategies, highlighting significant progress in radiotherapy, chemotherapy, and the emerging promise of immunotherapy and targeted treatments.
Effective screening with colonoscopy can detect precancerous lesions, reduce CRC incidence and mortality, and improve patient outcomes, making it a cornerstone of colorectal cancer prevention strategies.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E‑Mutated Colorectal Cancer
- Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
- Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics